Medivation Stock Gaps Up On Today's Open (MDVN)

NEW YORK ( TheStreet) -- Shares of Medivation (Nasdaq: MDVN) were gapping up Thursday morning with an open price 12.2% higher than Wednesday's closing price. The stock closed at $64.19 Wednesday and opened today's trading at $72.

The average volume for Medivation has been 926,800 shares per day over the past 30 days. Medivation has a market cap of $1.83 billion and is part of the health care sector and drugs industry. Shares are up 39.2% year to date as of the close of trading on Wednesday.

Medivation, Inc., a biopharmaceutical company, focuses on the development of small molecule drugs for the treatment of castration-resistant prostate cancer, Alzheimer's disease, and Huntington disease.

TheStreet Ratings rates Medivation as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. However, as a counter to these strengths, we find that the growth in the company's net income has been quite unimpressive. You can view the full Medivation Ratings Report.

Get more investment ideas from our investment research center.

Interested in other stocks that are gapping up? Get free SMS text alerts sent to you when the action happens by texting UP to 95370 or select from multiple alert options.
null

If you liked this article you might like

7 Hot Investing Bets to Make in Biotech

7 Hot Investing Bets to Make in Biotech

Biotech Movers: OncoMed Tanks After Barrage of Bad News, Akorn Rises on Deal Talk

Biotech Movers: OncoMed Tanks After Barrage of Bad News, Akorn Rises on Deal Talk

Medivation Founder Takes Helm at Axovant, Shares Spike

Medivation Founder Takes Helm at Axovant, Shares Spike

Second-Quarter Picks and Pans

Second-Quarter Picks and Pans

How I'd Play Biotech Buyout Rumors

How I'd Play Biotech Buyout Rumors